ArticleInternational journal of molecular sciences2020
Ecofriendly Synthesis of Silver Nanoparticles by
Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 44 citations in OpenAlex.
- Copper/Copper Oxide Nanoparticles: Biological Synthesis, Characterization and Potential Biomedical Applications: Advances and Perspectives.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Green Synthesis and Characterization of Silver Nanoparticles Using Traditional Medicinal Herb Phyllanthus Maderaspatensis for their Antibacterial and Anti-biofilm Activities.Applied biochemistry and biotechnology · 2026Article
- Advances of Green-Synthesized Nanoparticles for Biomedical Applications.BioMed research international · 2026Review
- Engineered Phage-Guided Nanotherapeutic Systems for Precision Antibacterial Therapy: Hacking Bacterial Resistance Mechanisms.Pharmaceutics · 2025Review
- Extracellular Synthesis of Bioactive Silver Nanoparticles UsingJournal of functional biomaterials · 2025Article
- Green Synthesis, Characterization, and Potential Antibacterial and Anticancer Applications of Gold Nanoparticles: Current Status and Future Prospects.Biomedicines · 2025Review
- Candidate avirulent effector protein 2565 reduces clubroot incidence via rhizosphere microbiome restructuring and root exudate modulation.Frontiers in microbiology · 2025Article
- Microbial- and Plant-Derived Bioactive Peptides and Their Applications against Foodborne Pathogens: Current Status and Future Prospects.International journal of microbiology · 2024Review
- Green Synthesis and Characterization of Silver Nanoparticles UsingPharmaceuticals (Basel, Switzerland) · 2023Article
- Optimization of the biosynthesis of silver nanoparticles using bacterial extracts and their antimicrobial potential.Biotechnology reports (Amsterdam, Netherlands) · 2023Article
- Bioactive ZnO Nanoparticles: Biosynthesis, Characterization and Potential Antimicrobial Applications.Pharmaceutics · 2023Review
- Bacterial mediated green synthesis of silver nanoparticles and their antibacterial and antifungal activities against drug-resistant pathogens.Royal Society open science · 2023Article
- Combating Microbial Infections Using Metal-Based Nanoparticles as Potential Therapeutic Alternatives.Antibiotics (Basel, Switzerland) · 2023Review
- Biosynthesis of Metal and Metal Oxide Nanoparticles Using Microbial Cultures: Mechanisms, Antimicrobial Activity and Applications to Cultural Heritage.Microorganisms · 2023Review
- Green synthesis of gold and silver nanoparticles using crude extract ofFrontiers in bioengineering and biotechnology · 2023Article
- Review
- Use of Nanoparticles to Prevent Resistance to Antibiotics-Synthesis and Characterization of Gold Nanosystems Based on Tetracycline.Pharmaceutics · 2022Article
- Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains ofPolymers · 2022Article
- Green Synthesis and Potential Antibacterial Applications of Bioactive Silver Nanoparticles: A Review.Polymers · 2022Review
- Green Metallic Nanoparticles: Biosynthesis to Applications.Frontiers in bioengineering and biotechnology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 5 institutions in 1 country.
Funding
Abstract
It is essential to develop and discover alternative eco-friendly antibacterial agents due to the emergence of multi-drug-resistant microorganisms. In this study, we isolated and characterized a novel bacterium named
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.